MMedication Read More Colorado can’t cap price of arthritis drug Enbrel, judge rulesJuly 7, 2026 Colorado can’t cap the price of arthritis medication Enbrel while a lawsuit challenging the state’s drug affordability board’s…
TTechnology Read More L’Oréal and Adeia Enter Multi-Year License AgreementMay 4, 2026 SAN JOSE, Calif., May 04, 2026 (GLOBE NEWSWIRE) — Adeia Inc. (Nasdaq: ADEA), the technology company known for…
MMedication Read More Ozempic is getting generics as low as $15 — what it means for AmericansMarch 19, 2026 The weight-loss world is on the brink of a major shake-up. Pharmaceutical companies in India will get the…
MMedication Read More Consumer group presses U.S. to authorize generic GLP-1sFebruary 13, 2026 Public Citizen petitioned the Trump administration to use a federal law to authorize generic competitors for GLP-1 drugs…
TTechnology Read More Sony Patents Buttonless Adaptive Controller With Customizable LayoutsJanuary 31, 2026 Xbox made waves not too long ago with the hyper-customizable Adaptive Controller that features remappable physical buttons, 19…
EEconomy Read More All the economic wins Keir Starmer wants to bag in China – POLITICOJanuary 28, 2026 For now, then, the aim is to secure progress in areas that are seen as less sensitive. Starmer’s…
HHealthcare Read More J&J wants to be the leader in the cancer fight. Its strategy is starting to pay off as oncology sales top $25 billion in 2025.January 21, 2026 Last Updated: Jan. 21, 2026 at 10:14 a.m. ETFirst Published: Jan. 21, 2026 at 7:26 a.m. ET Johnson & Johnson…
MMedication Read More Ozempic-style drugs should be available to all, not just the rich, says WHO – POLITICODecember 1, 2025 The WHO wants pharma companies to consider tiered pricing (lower prices in lower-income countries) and voluntary licensing of…
MMedication Read More Ireland’s ‘Viagra Village’ in the eye of Trump’s tariff storm – politico.euSeptember 23, 2025 Ireland’s ‘Viagra Village’ in the eye of Trump’s tariff storm politico.euWhat Trends Are You Seeing in Pharma Commercialization? PharmExecIreland faces…